Perceived experiences of people with severe haemophilia A switching from factor VIII prophylaxis to emicizumab
Linda Myrin-Westesson
Sahlgrenska University Hospital, Department of Medicine, Sahlgrenska Academy, Institution for Nursing Science and Health at Gothenburg UniversityGothenburg,
Profilo OrcidCerca questo autore su
e Anna Olsson
Sahlgrenska University Hospital, Department of Medicine, Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of GothenburgGothenburg,
Profilo OrcidCerca questo autore su
09 set 2025
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Clinical Research
Pubblicato online: 09 set 2025
Pagine: 87 - 95
DOI: https://doi.org/10.2478/jhp-2025-0011
Parole chiave
© 2025 Linda Myrin-Westesson et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.
Demographic and medical data of participants*
| Mean (SD) age, years | 33.1 (12.1) | |
| Family situation, n (%) | Married/Cohabiting | 5 (55.5) |
| Single | 4 (44.4) | |
| Education, n (%) | Elementary school | 1 (11.1) |
| Upper secondary school | 5 (55.5) | |
| College/University | 3 (33.3) | |
| Treatment before switch, n (%) | Prophylaxis with SHL | 4 (44.4) |
| Prophylaxis with EHL | 5 (55.6) | |
| Mean (SD) duration of emicizumab treatment (weeks) | 47.3 (3.3) | |
| Emicizumab treatment regimen | Once weekly | 8 (88.9) |
| Every 2 weeks | 1 (11.1) | |
| Every 4 weeks | 0 | |
| Target joints at baseline, n (%) | 2 (22.2) | |
| Mean calculated ABR before switch (95% CI) | 10.0 (4.79–18.38) | |
| Mean calculated ABR after switch (95% CI) | 2.0 (0.25–7.27) | |
| Joint health (based on HEAD-US scores42) at baseline, n (%) | Healthy joints | 4 (44.4) |
| Synovitis | 4 (44.4) | |
| Synovitis only | 1 (11.1) | |
| Synovitis and OCD | 3 (33.3) | |
| OCD only | 1 (11.1) | |
Categories and sub-categories of participant responses
| Adapting to a new reality | Learning the new treatment |
| The treatment takes less time and space in life | |
| New difficulties and different pain | |
| A feeling of normality | Changed situation in professional life |
| New prerequisites for physical activity | |
| Hope for the future | |
| Shattered expectations | The disease persists |
| The difference may not be significant |